Use of double negative regulatory T cell to induce tolerogenic dendritic cells and CD4+Foxp3+ regulatory T cells to develop donor-specific transplantation tolerance.
Use of double negative regulatory T cell to induce tolerogenic dendritic cells and CD4+Foxp3+ regulatory T cells to develop donor-specific transplantation tolerance.
批准号:
279435
负责人:
Lee Jong Bok
金额:
$1.27万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-02-01 至 2014-02-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Transplantation can save lives of people suffering from end-stage organ failure. Current therapy involves injection of immunosuppressive drugs to transplant recipients to prevent destruction of donated organs by recipients' immune system through a proces
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
-
批准号:488039
-
项目类别:Operating Grants
-
资助金额:$73.84万
-
财政年份:2023
-
负责人:Lee Jong Bok
-
依托单位:
Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD
-
批准号:493332
-
项目类别:
-
资助金额:$0.22万
-
财政年份:2023
-
负责人:Lee Jong Bok
-
依托单位:
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
-
批准号:498857
-
项目类别:Operating Grants
-
资助金额:$1.82万
-
财政年份:2023
-
负责人:Lee Jong Bok
-
依托单位:
Canada Research Chair - Tier 2
-
批准号:481581
-
项目类别:
-
资助金额:$43.71万
-
财政年份:2022
-
负责人:Lee Jong Bok
-
依托单位:
Characterization of human allogenenic double negative T cells as a novel immunotherapy against acute myeloid leukemia
-
批准号:318246
-
项目类别:Studentship Programs
-
资助金额:$10.93万
-
财政年份:2014
-
负责人:Lee Jong Bok
-
依托单位:
海外基金